Breathe Well Live Well
|
MediciNova to Present at American Academy of Emergency Medicine Annual Meeting
MarketWatch (press release) Kazuko Matsuda, MD, Ph.D, MPH, Chief Medical Officer of MediciNova, will provide an overview of current treatment practice in emergency departments for patients presenting with acute bronchospasms related to asthma or chronic obstructive pulmonary … |
View full post on asthma – Google News
|
Allergy & Asthma Network Mothers of Asthmatics Fills Cupid's Quiver with 10 …
MarketWatch (press release) Or is it the pollen, pet or mold allergies that have you worried about asthma symptoms flaring? Allergy & Asthma Network Mothers of Asthmatics (AANMA) offers these Cupid-studded tips. Dining out: It's one of the busiest nights of the year. |
View full post on asthma – Google News
|
MediciNova and University of Colorado Boulder Collaborate on Potential Novel …
MarketWatch (press release) Ibudilast has been used in asthma and post-stroke disorders in Japan for around 20 years. MediciNova has demonstrated utility of ibudilast in neurological disorders at higher doses with encouraging outcomes in company-sponsored clinical trials in … |
View full post on asthma – Google News
|
Inverseon Focuses on Mucous and Smoking Cessation
MarketWatch (press release) 12, 2012 /PRNewswire via COMTEX/ — Inverseon, Inc., a pharmaceutical company developing drug therapies for the treatment of pulmonary disorders, announced that while it anticipates that its asthma program will advance with non-dilutive grants, … |
View full post on asthma – Google News
|
Mississippi's Medicaid program adds coverage for Aerocrine's FeNO testing in …
MarketWatch (press release) Asthma is a chronic inflammatory disease of the airways that affects more than 300 million people worldwide, many of whom are children. FeNO is a marker of the underlying airway inflammation associated with asthma, and Aerocrine has developed a method … |
View full post on asthma – Google News
|
Boston Scientific's Alair® Bronchial Thermoplasty System Achieves Important …
MarketWatch (press release) "It supports what we have confirmed through our clinical trials: bronchial thermoplasty offers a new advancement in the treatment of patients with severe asthma who are not well controlled despite taking recommended doses of asthma medications. … |
View full post on asthma – Google News
|
St. Luke's Episcopal Hospital Offers Bronchial Thermoplasty Treating Severe …
MarketWatch (press release) Affecting almost 25 million Americans, asthma is one of the top five chronic diseases globally, along with heart disease, stroke, cancer and diabetes. Patients treated with this minimally invasive, outpatient procedure have shown a decrease in severe … |
View full post on asthma – Google News
|
Dynavax and AstraZeneca Agree to Conduct Toxicology Studies for TLR-9 Agonist …
MarketWatch (press release) These include demonstration that AZD1419 is capable of producing long lasting disease-modifying effects in a mouse model of atopic asthma. Under the terms of the amended 2006 research collaboration and license agreement, AstraZeneca will provide to … |
View full post on asthma – Google News
|
NFL Legend Jerome Bettis Joins with Clean Air Council to Advocate for …
MarketWatch (press release) The rule, which would require the first nationwide reductions of hazardous emissions of mercury, lead, arsenic, and acid gases from coal-fired power plants, would save up to 17000 lives and prevent 120000 cases of aggravated asthma a year, according to … |
View full post on asthma – Google News
|
Final 'Build Smart, Breathe Easier' House with Asthma-Healthy Features …
MarketWatch (press release) 9, 2011 /PRNewswire via COMTEX/ — The last of four Habitat for Humanity houses built across the United States as part of the Build Smart, Breathe Easier national asthma education program will be dedicated in partnership with the Obele family in the … |
View full post on asthma – Google News